£2.0M
Deepbridge Capital provides follow-on funding to accelerate preclinical pipelines and targeted therapies.
"We are delighted that Deepbridge has continued to support our future development."
Funding Announcements
Filter
Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
308
Total raised
£4.1B
disclosed amounts
This month
£27.8M
raised so far
£8.4M
Vickers Venture Partners led the Series A round to support clinical trials for set-point vaccines.
"Attracting such high calibre investors is an endorsement of our development pipeline and validation of the potential our technologies hold in the field of infectious diseases. These new funds will support us to achieve some significant value-enhancing milestones as we progress our lead vaccine candidates into clinical development."
£7.0M
The seed round was backed by Amadeus Capital Partners, Delin Ventures and Kindred Capital to fund the commercial launch of its manufacturing technology.
"Hundreds of clinical trials and a few recently marketed products have shown the revolutionary potential of CGTs. But this potential will never be realised unless we can remove the current bottleneck around scalable manufacturing. Ori Biotech has developed an innovative platform technology to facilitate scalable manufacturing that could eventually enable millions of patients to get access to the next generation of personalised medicines,"
£1.0M
The financing round was supported by Equity Gap, Scottish Investment Bank, Old College Capital and Hillhouse Group.
"MiAlgae has essentially taken a by-product from one industry and turned it into a solution for another industry. Through the application of biotechnology, MiAlgae is finding solutions to feed the world’s population, and with the global aquaculture industry set to double in size in the next ten years, this is a very promising business indeed."
Equity Gap + 3 others
£29.3M
The company secured new capital from international investors across the US, Europe, and Asia.